---
title: | Pipeline & Clinical Insights
description: Pipeline & Clinical Insights |
---

## [![](https://blog.sen-jam.com/hs-fs/hubfs/sen-jam%20logo-1.png?width=1952&height=522&name=sen-jam%20logo-1.png)](http://www.sen-jam.com)

[Follow us on Facebook ](https://www.facebook.com) [Follow us on LinkedIn ](https://www.linkedin.com) [Follow us on Twitter ](https://www.twitter.com) [Follow us on Instagram ](https://www.instagram.com) 

[✕](https://blog.sen-jam.com/stories/tag/pipeline-clinical-insights#logen-offcanvas-primary)

# Pipeline & Clinical Insights

[![](https://blog.sen-jam.com/hubfs/beautiful-young-woman-meditating-exercising-top-him.jpg) ](https://blog.sen-jam.com/stories/biggest-problem-inflamation)

[![Sen-Jam](https://blog.sen-jam.com/hubfs/New%20SJP%20Favicon-1.png) ](https://blog.sen-jam.com/stories/author/senjam)

[Sen-Jam](https://blog.sen-jam.com/stories/author/senjam) 06-6-2026 

[News & Company Updates](https://blog.sen-jam.com/stories/tag/news-company-updates)

### [The Biggest Problem in Modern Medicine: Inflammation](https://blog.sen-jam.com/stories/biggest-problem-inflamation)

<https://blog.sen-jam.com/stories/biggest-problem-inflamation>

[![](https://blog.sen-jam.com/hubfs/Screen-Shot-2025-10-02-at-10.46.51-AM-2048x1219.png) ](https://blog.sen-jam.com/stories/european-biopharma-obesity-innovation-forum)

[![Sen-Jam](https://blog.sen-jam.com/hubfs/New%20SJP%20Favicon-1.png) ](https://blog.sen-jam.com/stories/author/senjam)

[Sen-Jam](https://blog.sen-jam.com/stories/author/senjam) 11-4-2025 

[News & Company Updates](https://blog.sen-jam.com/stories/tag/news-company-updates)

### [Sen-Jam Pharmaceutical Takes the Stage at European Biopharma Obesity Innovation Forum](https://blog.sen-jam.com/stories/european-biopharma-obesity-innovation-forum)

<https://blog.sen-jam.com/stories/european-biopharma-obesity-innovation-forum>

[![](https://blog.sen-jam.com/hubfs/Screenshot%202026-02-16%20at%206.00.00%20PM.png) ](https://blog.sen-jam.com/stories/executive-leadership-destum-partners)

[![Sen-Jam](https://blog.sen-jam.com/hubfs/New%20SJP%20Favicon-1.png) ](https://blog.sen-jam.com/stories/author/senjam)

[Sen-Jam](https://blog.sen-jam.com/stories/author/senjam) 27-5-2025 

[News & Company Updates](https://blog.sen-jam.com/stories/tag/news-company-updates)

### [Behind the Breakthrough: Strategic Insights from Sen-Jam's Executive Leadership and Destum Partners](https://blog.sen-jam.com/stories/executive-leadership-destum-partners)

<https://blog.sen-jam.com/stories/executive-leadership-destum-partners>

[![](https://blog.sen-jam.com/hubfs/March-IP-Update-KVK-tech-Engineering-Batches.jpg) ](https://blog.sen-jam.com/stories/patent-milestone-stability-data-strengthen-licensing-value-sjp-002c)

[![Sen-Jam](https://blog.sen-jam.com/hubfs/New%20SJP%20Favicon-1.png) ](https://blog.sen-jam.com/stories/author/senjam)

[Sen-Jam](https://blog.sen-jam.com/stories/author/senjam) 23-1-2025 

[News & Company Updates](https://blog.sen-jam.com/stories/tag/news-company-updates)

### [Patent Milestone and Stability Data Strengthen Licensing Value of SJP-002C](https://blog.sen-jam.com/stories/patent-milestone-stability-data-strengthen-licensing-value-sjp-002c)

<https://blog.sen-jam.com/stories/patent-milestone-stability-data-strengthen-licensing-value-sjp-002c>

[![](https://blog.sen-jam.com/hubfs/eid-ashley-lauren-st-john-portrait-1.png) ](https://blog.sen-jam.com/stories/immunology-infectious-disease-dr-ashley-st-john-advisory-board)

[![Sen-Jam](https://blog.sen-jam.com/hubfs/New%20SJP%20Favicon-1.png) ](https://blog.sen-jam.com/stories/author/senjam)

[Sen-Jam](https://blog.sen-jam.com/stories/author/senjam) 11-3-2025 

[News & Company Updates](https://blog.sen-jam.com/stories/tag/news-company-updates)

### [Sen-Jam Pharmaceutical Welcomes Immunology and Infectious Disease Expert Dr. Ashley St. John to its Scientific Advisory Board](https://blog.sen-jam.com/stories/immunology-infectious-disease-dr-ashley-st-john-advisory-board)

<https://blog.sen-jam.com/stories/immunology-infectious-disease-dr-ashley-st-john-advisory-board>

[![](https://blog.sen-jam.com/hubfs/partnerships.jpg) ](https://blog.sen-jam.com/stories/destum-partners-sjp-001-sjp-002c)

[![Sen-Jam](https://blog.sen-jam.com/hubfs/New%20SJP%20Favicon-1.png) ](https://blog.sen-jam.com/stories/author/senjam)

[Sen-Jam](https://blog.sen-jam.com/stories/author/senjam) 10-2-2025 

[News & Company Updates](https://blog.sen-jam.com/stories/tag/news-company-updates)

### [Sen-Jam Pharmaceutical Engages Destum Partners to Source Strategic Partnerships for SJP-001 & SJP-002C](https://blog.sen-jam.com/stories/destum-partners-sjp-001-sjp-002c)

<https://blog.sen-jam.com/stories/destum-partners-sjp-001-sjp-002c>

[![](https://blog.sen-jam.com/hubfs/Toast.png) ](https://blog.sen-jam.com/stories/pharmaceutical-therapeutic-aimed-at-tackling-alcohol-related-risks)

[![Sen-Jam](https://blog.sen-jam.com/hubfs/New%20SJP%20Favicon-1.png) ](https://blog.sen-jam.com/stories/author/senjam)

[Sen-Jam](https://blog.sen-jam.com/stories/author/senjam) 25-7-2025 

[News & Company Updates](https://blog.sen-jam.com/stories/tag/news-company-updates)

### [Sen-Jam Pharmaceutical Answers Surgeon General's Alarm with a New Therapeutic Aimed at Tackling Alcohol Related Risks](https://blog.sen-jam.com/stories/pharmaceutical-therapeutic-aimed-at-tackling-alcohol-related-risks)

<https://blog.sen-jam.com/stories/pharmaceutical-therapeutic-aimed-at-tackling-alcohol-related-risks>

[![](https://blog.sen-jam.com/hubfs/Preliminary-Positive-Results-1-scaled-1.webp) ](https://blog.sen-jam.com/stories/phase-2-clinical-trials-sjp-002c-upper-respiratory-infections-covid-19)

[![Sen-Jam](https://blog.sen-jam.com/hubfs/New%20SJP%20Favicon-1.png) ](https://blog.sen-jam.com/stories/author/senjam)

[Sen-Jam](https://blog.sen-jam.com/stories/author/senjam) 15-4-2025 

[News & Company Updates](https://blog.sen-jam.com/stories/tag/news-company-updates)

### [Sen-Jam Pharmaceutical Announces Preliminary Results from Phase 2 Clinical Trials of SJP-002C for Upper Respiratory Infections/COVID-19](https://blog.sen-jam.com/stories/phase-2-clinical-trials-sjp-002c-upper-respiratory-infections-covid-19)

<https://blog.sen-jam.com/stories/phase-2-clinical-trials-sjp-002c-upper-respiratory-infections-covid-19>

[![](https://blog.sen-jam.com/hubfs/pair-technology-methabolic-balance.jpg) ](https://blog.sen-jam.com/stories/inflammatory-care-pair-technology-metabolic-balance-inflammation-resolution)

[![Sen-Jam](https://blog.sen-jam.com/hubfs/New%20SJP%20Favicon-1.png) ](https://blog.sen-jam.com/stories/author/senjam)

[Sen-Jam](https://blog.sen-jam.com/stories/author/senjam) 14-3-2025 

[News & Company Updates](https://blog.sen-jam.com/stories/tag/news-company-updates)

### [Sen-Jam Pharmaceutical: Revolutionizing Inflammatory Care with Proprietary PAIR Technology for Metabolic Balance and Inflammation Resolution](https://blog.sen-jam.com/stories/inflammatory-care-pair-technology-metabolic-balance-inflammation-resolution)

<https://blog.sen-jam.com/stories/inflammatory-care-pair-technology-metabolic-balance-inflammation-resolution>

[![](https://blog.sen-jam.com/hubfs/Screen%20Shot%202026-03-12%20at%202.58.43%20PM.png) ](https://blog.sen-jam.com/stories/sen-jam-pharmaceutical-files-groundbreaking-patent-for-novel-therapeutic-approach-to-address-obesity-and-metabolic-disorders)

[![Sen-Jam](https://blog.sen-jam.com/hubfs/New%20SJP%20Favicon-1.png) ](https://blog.sen-jam.com/stories/author/senjam)

[Sen-Jam](https://blog.sen-jam.com/stories/author/senjam) 09-5-2025 

[News & Company Updates](https://blog.sen-jam.com/stories/tag/news-company-updates)

### [Sen-Jam Pharmaceutical Files Groundbreaking Patent for Novel Therapeutic Approach to Address Obesity and Metabolic Disorders](https://blog.sen-jam.com/stories/sen-jam-pharmaceutical-files-groundbreaking-patent-for-novel-therapeutic-approach-to-address-obesity-and-metabolic-disorders)

<https://blog.sen-jam.com/stories/sen-jam-pharmaceutical-files-groundbreaking-patent-for-novel-therapeutic-approach-to-address-obesity-and-metabolic-disorders>